CoChat

Antidepressant efficacy in relation to item analysis and severity of depression: a placebo-controlled trial of fluvoxamine versus imipramine

Kasper, S., Möller, H. -J., Montgomery, S. A., Zondag, E. · 1995 · International Clinical Psychopharmacology

The DOI matches its Crossref record.

Abstract

In this investigation, the antidepressant efficacy of fluvoxamine and imipramine was compared in a randomized, double-blind, placebo-controlled study lasting 4 weeks; 338 depressed patients were recruited at five North American centres. For the efficacy analyses an intent-to-treat sample was defined. The global efficacy of the two drugs was assessed by the Hamilton Depression scale (HAM-D) and Clinical Global Impression (CGI) scores. Antidepressant activity was also assessed using the percentage of responders on the CGI "improvement" scale. In addition the time of onset of antidepressant effect was evaluated by weekly analysis of individual HAM-D items. The intent-to-treat sample was stratified retrospectively according to the severity of the depression (mild, moderate or severe). Regarding global efficacy, compared with placebo, only fluvoxamine significantly improved the HAM-D total scores at Week 4 (p < 0.05). There was a suggestion from individual HAM-D item scores (depressed mood, suicide, psychic anxiety) that fluvoxamine had an earlier effect than imipramine. Overall, compared with placebo, more HAM-D items were improved by fluvoxamine than imipramine. Fluvoxamine but not imipramine was significantly superior to placebo in severely depressed patients as shown by improvements in the HAM-D score (p < 0.01) and the CGI "improvement" score (p < 0.05). Side effect profiles for the active agents were typical for their pharmacological category:imipramine was associated with anticholinergic effects, particularly dry mouth, and fluvoxamine was associated with nausea and vomiting.

Overview

Integrity signals

Registry

Crossref · 10.1097/00004850-199501004-00001

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Still being checked.

Cited by

See all 37

Metadata

Authors
Kasper, S., Möller, H. J., Montgomery, S. A., & Zondag, E.
Affiliations
  • University of Vienna (AT)
  • Ludwig-Maximilians-Universität München (DE)
  • St Mary's Hospital (GB)
  • Solvay (Netherlands) (NL)
Venue
International Clinical Psychopharmacology
Published
1995-01
Volume
9
Pages
3-12
ISSN
0268-1315 (ISSN-L)
OpenAlex
W1976123171
Cited by
37
References
0
Citations by year
2019: 1 · 2018: 1 · 2016: 2 · 2015: 1 · 2012: 1
FWCI
2.39
Type
journal article
Language
en
Open access
closed
Locations
  • International Clinical Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
Keywords
fluvoxamine, imipramine, antidepressant efficacy, depression severity, item analysis, Hamilton Depression Rating Scale, Clinical Global Impression Scale, anticholinergic effects, nausea and vomiting
MeSH terms
Adult, Depressive Disorder, Double-Blind Method, Female, Humans, Imipramine, Male, Middle Aged, Placebos, Psychiatric Status Rating Scales, Retrospective Studies, Severity of Illness Index, Fluvoxamine, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Antidepressant efficacy in relation to item analysis and severity of depression: a placebo-controlled trial of fluvoxamine versus imipramine. https://app.cochat.ai/papers/10.1097/00004850-199501004-00001
The paper
Kasper, S., Möller, H. J., Montgomery, S. A., & Zondag, E. (1995). Antidepressant efficacy in relation to item analysis and severity of depression: a placebo-controlled trial of fluvoxamine versus imipramine. International Clinical Psychopharmacology. https://doi.org/10.1097/00004850-199501004-00001

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.